The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Human Insulin-Global Market Insights and Sales Trends 2024

Human Insulin-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1844139

No of Pages : 102

Ask Your Query

Synopsis

Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.

The global Human Insulin market size is expected to reach US$ 105620 million by 2029, growing at a CAGR of 9.4% from 2023 to 2029. The market is mainly driven by the significant applications of Human Insulin in various end use industries. The expanding demands from the Short Acting, Intermediate Acting, Long Acting and Pre-Mix Insulin, are propelling Human Insulin market. Insulin Analogs and Biosimilars, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Human Insulin Biologics segment is estimated at % CAGR for the next seven-year period.

In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Insulin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Human Insulin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Human Insulin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Insulin sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Human Insulin covered in this report include B. Braun, Becton, Dickinson, Biocon, Biodel, ELI Lilly, Julphar, NOVO Nordisk, Sanofi and Wockhardt, etc.

The global Human Insulin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • B. Braun
  • Becton, Dickinson
  • Biocon
  • Biodel
  • ELI Lilly
  • Julphar
  • NOVO Nordisk
  • Sanofi
  • Wockhardt
  • Ypsomed

Global Human Insulin market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Human Insulin market, Segment by Type:

  • Insulin Analogs and Biosimilars
  • Human Insulin Biologics

Global Human Insulin market, by Application

  • Short Acting
  • Intermediate Acting
  • Long Acting
  • Pre-Mix Insulin

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Insulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Human Insulin Market Overview
1.1 Human Insulin Product Overview
1.2 Human Insulin Market Segment by Type
1.2.1 Insulin Analogs and Biosimilars
1.2.2 Human Insulin Biologics
1.3 Global Human Insulin Market Size by Type
1.3.1 Global Human Insulin Market Size Overview by Type (2018-2029)
1.3.2 Global Human Insulin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Insulin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Insulin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Insulin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Insulin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Insulin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Insulin Sales Breakdown by Type (2018-2023)
2 Global Human Insulin Market Competition by Company
2.1 Global Top Players by Human Insulin Sales (2018-2023)
2.2 Global Top Players by Human Insulin Revenue (2018-2023)
2.3 Global Top Players by Human Insulin Price (2018-2023)
2.4 Global Top Manufacturers Human Insulin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Insulin Market Competitive Situation and Trends
2.5.1 Human Insulin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Insulin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Insulin as of 2022)
2.7 Date of Key Manufacturers Enter into Human Insulin Market
2.8 Key Manufacturers Human Insulin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Insulin Status and Outlook by Region
3.1 Global Human Insulin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Insulin Historic Market Size by Region
3.2.1 Global Human Insulin Sales in Volume by Region (2018-2023)
3.2.2 Global Human Insulin Sales in Value by Region (2018-2023)
3.2.3 Global Human Insulin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Insulin Forecasted Market Size by Region
3.3.1 Global Human Insulin Sales in Volume by Region (2024-2029)
3.3.2 Global Human Insulin Sales in Value by Region (2024-2029)
3.3.3 Global Human Insulin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Insulin by Application
4.1 Human Insulin Market Segment by Application
4.1.1 Short Acting
4.1.2 Intermediate Acting
4.1.3 Long Acting
4.1.4 Pre-Mix Insulin
4.2 Global Human Insulin Market Size by Application
4.2.1 Global Human Insulin Market Size Overview by Application (2018-2029)
4.2.2 Global Human Insulin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Insulin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Insulin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Insulin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Insulin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Insulin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Insulin Sales Breakdown by Application (2018-2023)
5 North America Human Insulin by Country
5.1 North America Human Insulin Historic Market Size by Country
5.1.1 North America Human Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Insulin Sales in Volume by Country (2018-2023)
5.1.3 North America Human Insulin Sales in Value by Country (2018-2023)
5.2 North America Human Insulin Forecasted Market Size by Country
5.2.1 North America Human Insulin Sales in Volume by Country (2024-2029)
5.2.2 North America Human Insulin Sales in Value by Country (2024-2029)
6 Europe Human Insulin by Country
6.1 Europe Human Insulin Historic Market Size by Country
6.1.1 Europe Human Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Insulin Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Insulin Sales in Value by Country (2018-2023)
6.2 Europe Human Insulin Forecasted Market Size by Country
6.2.1 Europe Human Insulin Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Insulin Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Insulin by Region
7.1 Asia-Pacific Human Insulin Historic Market Size by Region
7.1.1 Asia-Pacific Human Insulin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Insulin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Insulin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Insulin Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Insulin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Insulin Sales in Value by Region (2024-2029)
8 Latin America Human Insulin by Country
8.1 Latin America Human Insulin Historic Market Size by Country
8.1.1 Latin America Human Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Insulin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Insulin Sales in Value by Country (2018-2023)
8.2 Latin America Human Insulin Forecasted Market Size by Country
8.2.1 Latin America Human Insulin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Insulin Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Insulin by Country
9.1 Middle East and Africa Human Insulin Historic Market Size by Country
9.1.1 Middle East and Africa Human Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Insulin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Insulin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Insulin Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Insulin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Insulin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 B. Braun
10.1.1 B. Braun Company Information
10.1.2 B. Braun Introduction and Business Overview
10.1.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 B. Braun Human Insulin Products Offered
10.1.5 B. Braun Recent Development
10.2 Becton, Dickinson
10.2.1 Becton, Dickinson Company Information
10.2.2 Becton, Dickinson Introduction and Business Overview
10.2.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Becton, Dickinson Human Insulin Products Offered
10.2.5 Becton, Dickinson Recent Development
10.3 Biocon
10.3.1 Biocon Company Information
10.3.2 Biocon Introduction and Business Overview
10.3.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Biocon Human Insulin Products Offered
10.3.5 Biocon Recent Development
10.4 Biodel
10.4.1 Biodel Company Information
10.4.2 Biodel Introduction and Business Overview
10.4.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Biodel Human Insulin Products Offered
10.4.5 Biodel Recent Development
10.5 ELI Lilly
10.5.1 ELI Lilly Company Information
10.5.2 ELI Lilly Introduction and Business Overview
10.5.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 ELI Lilly Human Insulin Products Offered
10.5.5 ELI Lilly Recent Development
10.6 Julphar
10.6.1 Julphar Company Information
10.6.2 Julphar Introduction and Business Overview
10.6.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Julphar Human Insulin Products Offered
10.6.5 Julphar Recent Development
10.7 NOVO Nordisk
10.7.1 NOVO Nordisk Company Information
10.7.2 NOVO Nordisk Introduction and Business Overview
10.7.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 NOVO Nordisk Human Insulin Products Offered
10.7.5 NOVO Nordisk Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Information
10.8.2 Sanofi Introduction and Business Overview
10.8.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Human Insulin Products Offered
10.8.5 Sanofi Recent Development
10.9 Wockhardt
10.9.1 Wockhardt Company Information
10.9.2 Wockhardt Introduction and Business Overview
10.9.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Wockhardt Human Insulin Products Offered
10.9.5 Wockhardt Recent Development
10.10 Ypsomed
10.10.1 Ypsomed Company Information
10.10.2 Ypsomed Introduction and Business Overview
10.10.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Ypsomed Human Insulin Products Offered
10.10.5 Ypsomed Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Insulin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Insulin Industrial Chain Analysis
11.4 Human Insulin Market Dynamics
11.4.1 Human Insulin Industry Trends
11.4.2 Human Insulin Market Drivers
11.4.3 Human Insulin Market Challenges
11.4.4 Human Insulin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Insulin Distributors
12.3 Human Insulin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock